The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID‐19: A meta‐analysis of randomized trials

Abstract Background Overactivation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome can lead to severe illness in patients with coronavirus disease‐2019 (COVID‐19). The NLRP3 inhibitor, colchicine, therefore, appears to be promising for the treatment of COVID‐19. Aims We aimed to per...

Full description

Saved in:
Bibliographic Details
Main Authors: Chia Siang Kow, Learn‐Han Lee, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Long Chiau Ming, Hui Poh Goh
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.562
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items